Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxelidine vs sufentanil for postoperative pain after knee arthroplasty
ChiCTR2500110632Phase 4Not yet recruiting
- Sponsor
- The Third Hospital of Hebei Medical University
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in postoperative pain and Postoperative pain following knee arthroplasty (2 arms), sponsored by The Third Hospital of Hebei Medical University. Primary endpoint: NRS score. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative painPostoperative pain following knee arthroplasty
Beyond the preview
Go deeper on ChiCTR2500110632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110632.